Lincoln Pharmaceuticals

Technopedia Center

Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education

Lincoln Pharmaceuticals - Wikipedia

From Wikipedia, the free encyclopedia

Lincoln Pharmaceuticals Limited
Company type	Public
Traded as	BSE: 531633 NSE: LINCOLN
Industry	Pharmaceuticals
Founded	1979 (45 years ago) (1979)
Founder	Mahendra G Patel Rajnikant G Patel Hasmukhbhai I Patel
Headquarters	Ahmedabad, Gujarat, India
Area served	Worldwide
Key people	Mahendra Patel (MD) Munjal M. Patel Ashish R. Patel Anand A. Patel Hasmukhbai I. Patel
Products	Pharmaceuticals generic drugs over-the-counter drugs
Revenue	₹580.54 crore (US$70 million) (FY24)^[1]
Operating income	₹134.33 crore (US$16 million) (FY24)^[1]^[2]
Net income	₹93.37 crore (US$11 million) (FY24)^[1]
Number of employees	1700+ (2024)
Website	www.lincolnpharma.com

Lincoln Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. Lincoln Pharmaceuticals is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.^[3]^[4]

Lincoln Pharmaceuticals is listed on National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).^[5]^[6]

History

Lincoln Pharmaceuticals was established in 1979 in Ahmedabad, Gujarat by Mr. Mahendra G Patel, Rajnikant G Patel, and Hasmukhbhai I Patel.^[7]

In the year 1996, Lincoln Pharma launched IPO and was listed on Bombay Stock Exchange. By the year 2000, the company's products were available in 80% of the domestic market across India. In 2010-11 the company launched three NDDS products.^[7]

In collaboration with Phafag AG, Switzerland, Lincoln Pharmaceuticals launched "Tinnex Injection" in India for Tinnitus disease. Tinnitus is commonly known as “bell ringing in the ear”.^[8]

In February 2015, Lincoln Pharmaceuticals was listed on National Stock Exchange of India.

Lincoln Pharma introduced the Ondansetron oral spray in India in September 2016. Ondansetron is administered to prevent emesis and nausea induced by cancer chemotherapy, radiation therapy, and surgical procedures.^[9]

In 2017, The company received a patent for the anti-malarial drug by Indian Government. This patent is provided for an Arteether injection to treat Malaria disease.^[10]

In May 2020, Lincoln Pharma received European Union (EU) GMP certification from EudraGMP for its Khatraj facility.^[11]

In 2021, the company Acquired a plant in Mehsana (Gujarat) to launch Cephalosporin products.^[12]

In September 2021, the National Company Law Tribunal (NCLT) approved the merging of Lincoln Parenteral with Lincoln Pharmaceuticals.^[13]

In October 2021, Lincoln Pharma received Australia's Therapeutic Goods Administration (TGA) certification for its Gujarat plant.^[14]

Operations

Lincoln Pharmaceuticals has two manufacturing facilities in Ahmedabad and Mehsana cities of Gujarat state certified by ISO 9001:2015 and it received WHO cGMP (The World Health Organization for following Good Manufacturing Practices) in 1984.^[7]

Lincoln's manufacturing facility is approved by European Union (EU) GMP from EudraGMP, (Therapeutic Goods Administration) TGA - Australia and over 60 Country's Drug Authorities.^[15]^[16]

Lincoln manufactures pharma formulations in various dosage forms like Tablets, Capsules, Dry Syrup, Cream, Non Sterile & Sterile Ointment, Dry Powder Injection, Ampoules Injection, Liquid Vials, Eye Drops, Oral Liquid, etc. Lincoln Pharma has a diversified portfolio with 1,700 plus product registrations, registered products in the above markets, and another 700 products in the pipeline.^[17]^[18]

Awards & honors

Gujarat SME Excellence Award^[19]

References

^ ^a ^b ^c "Lincoln Pharma 2024 Report" (PDF). BSE India.
^ "Lincoln Pharma net rises 29% to ₹93.37cr in FY24". The Times of India. 17 May 2024.
^ "Top Gujarat companies deliver up to 108% returns since last Diwali". The Times of India. 14 November 2023.
^ "Lincoln Pharma gets Gujarat food & drug regulator nod to manufacture COVID-19 drugs". The Economic Times. 27 April 2020.
^ "Stock Share Price- BSE". BSE India.
^ "Lincoln PharmaCeuticals". NSE.
^ ^a ^b ^c "Lincoln Pharmaceuticals Limited: A Healthcare Pioneer with Global Presence". Bru Times News.
^ "Tinnex injection launched". The Hindu. 18 April 2011.
^ "Lincoln Pharma launches Ondansetron oral spray in India - ET HealthWorld | Pharma". ETHealthworld.
^ "Lincoln Pharma gets patent for anti-malarial drug". The Economic Times. 19 December 2017.
^ "Lincoln Pharma gets EU GMP nod for Khatraj facility". BusinessLine. 19 May 2020.
^ "Soaring high: Lincoln Pharmaceuticals maintains a solid growth trajectory". The Economic Times. 17 August 2022.
^ "NCLT approves amalgamation of Lincoln Parenteral & Lincoln Pharmaceuticals - ET HealthWorld | Pharma". Economic Times.
^ "Lincoln Pharma gets Australia's TGA certification for Gujarat plant". BusinessLine. 8 October 2021.
^ "Lincoln Pharma launches chewable vitamin C, zinc tablets". BusinessLine. 30 July 2020.
^ "Gujarat's pharma industry growth hits 'fever pitch'". The Times of India. 4 September 2023.
^ "Lincoln Pharmaceuticals Limited Report" (PDF). Business Standard.
^ "Lincoln Pharmaceuticals Ltd achieves the milestone of Profit Growth Every Single year from FY13 to FY23". Ahmedabad Mirror.
^ "Indian SME Knowledge Forum". SME Chamber of India.

Categories:

Hidden categories: